Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine to prevent periprocedural myonecrosis in elective coronary angioplasty
NCT01148147Phase 3Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Nov 2009
- Primary completion
- Aug 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of adenosine in myocardial infarction (MI), sponsored by Azienda Ospedaliero-Universitaria Maggiore della Carità. Primary endpoint: Increase in troponin I (> 3 times the upper normal limit) at 12 hours. Started Nov 2009; status: completed.
02
Drugs
adenosine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01148147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01148147.